<--- Back to Details
First PageDocument Content
Clinical research / Orphan drug / Pharmaceuticals policy / Orphan Drug Act / Pharmacology / European Medicines Agency / Rare disease / Pharmaceutical drug / Alopecia totalis / Pharmaceutical sciences / Health / Drug discovery
Date: 2013-10-29 14:03:04
Clinical research
Orphan drug
Pharmaceuticals policy
Orphan Drug Act
Pharmacology
European Medicines Agency
Rare disease
Pharmaceutical drug
Alopecia totalis
Pharmaceutical sciences
Health
Drug discovery

Presentazione standard di PowerPoint

Add to Reading List

Source URL: www1.wfh.org

Download Document from Source Website

File Size: 1,15 MB

Share Document on Facebook

Similar Documents

The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DocID: 1vrLd - View Document

7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme

DocID: 1vlIp - View Document

The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP

DocID: 1ucvu - View Document

2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use

DocID: 1sVev - View Document

European Medicines Agency: Celebrating 20 years

DocID: 1sUY9 - View Document